Newsmeme!
Discover News you didn't know existed
Lantus
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Diabetes drug may have cancer risk: Health Canada
Published July 9, 2009, 2:17 pm, CTV Toronto
Health Canada is investigating the diabetes drug Lantus after research suggested there may be an increased risk of developing various types of cancer among those taking the medication.
Cancer-insulin link probed by Health Canada
Published July 9, 2009, 1:34 pm, CBC.ca
Health Canada is investigating a potential link between a long-acting, synthetic form of insulin and an increased risk of cancer, the department said Thursday.
Health Canada Update About Safety of Lantus (Insulin Glargine)
Published July 9, 2009, 10:40 am, Marketwire
OTTAWA, ONTARIO--(Marketwire - July 9, 2009) - Health Canada is informing Canadians of an ongoing safety review of the potential association between the diabetes drug Lantus (insulin glargine) and an increased risk of developing cancer. A similar review was recently announced by the U.S. Food and Drug Administration and the European Medicines Agency in light of four recently published studies ...
Health Buzz: Painkillers Get Warning and Other Health News
Published July 8, 2009, 9:46 am, US News & World Report
Best nursing homes nationwide—a brand-new honor roll; 5 risks linked to some diabetes drugs.
Lantus May Increase Cancer Risk
Published July 8, 2009, 1:43 am, HealthandAge
According to the US Food and Drug Administration (FDA), insulin glargine, marketed as Lantus®, may be associated with an increased risk for cancer. Lantus is a modified version of human insulin that has the advantage of allowing blood sugar control for extended periods of time.
When Bad News Hits, Drugmakers May See Stock Prices Fall
Published July 7, 2009, 3:01 pm, US News & World Report
Recent bad news on diabetes drugs resulted in loss of pharmaceutical manufacturers' stock values.
5 Risks Linked to Diabetes Medications Like Lantus, Avandia, Actos
Published July 7, 2009, 2:46 pm, US News & World Report
Cancer, heart failure, fractures, and eye and liver problems among some diabetes drugs' possible risks.
5-Year Study Published In Diabetologia Demonstrated Long-Term Safety Of Lantus(R) Compared To NPH
Published July 7, 2009, 5:14 am, Medical News Today
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the results of the long-term, 5-year study of Lantus(R) (insulin glargine [rDNA] injection) versus NPH insulin on progression of retinopathy in patients with type 2 diabetes, published on-line in Diabetologia (DOI 10.1007/s00125-009-1415-7) showed similar effects on retinopathy and overall safety in the two treatment groups.
Sanofi-aventis' Lantus 5-yr study shows safety & efficiency
Published July 6, 2009, 10:48 pm, PharmaBiz
Sanofi-aventis announced that the results of the long-term, five-year study of Lantus (insulin glargine [rDNA] injection) versus NPH insulin on progression of retinopathy in patients with type-2 diabetes, published on-line in Diabetologia (DOI 10.1007/s00125-009-1415-7) showed similar effects on retinopathy and overall safety in the two treatment groups.
Insulin analog glargine may up cancer risk
Published July 6, 2009, 8:00 pm, redOrbit
German medical researchers say they've determined diabetics who use the long-acting insulin analog glargine might face an increased risk of cancer. Scientists at the Institute for Quality and Efficiency in Health Care, in collaboration with the research institute of the German Local Health Care Fund, analyzed data from nearly 130,000 diabetes patients who had been treated with either human ...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |